Rationale: Due to accelerated germ cell loss, infertility is a major problem in girls with Turner syndrome (TS). Therefore, cryopreservation of ovarian tissue or oocytes before exhaustion of the ovarian reserve may preserve fertility in patients with TS. However, in the majority of females with TS , the ovarian reserve is exhausted before the age of menarche. Early markers indicating and predicting the ovarian reserve are necessary. During mid-childhood the hypothalamic-pituitary-gonadal (HPG) axis is quiescent and gonadotropins are usually unmeasurable. Nonetheless, this axis is active during infancy. Therefore, gonadotropins are measurable with peak values at 3 months of age and with lower (but still measurable) values at 9 months of age, in a period called the minipuberty. The aim of this study is to find markers of ovarian capacity, during the minipuberty, in order to predict ovarian reserve in the future. Objective: The hormonal range of LH, FSH, AMH, inhibin B, testosterone and estradiol in girls with TS during the minipuberty and the relation of the hormone serum levels with the karyotype. Study design: A prospective, cohort study with a duration of 3 years. Study population: Girls with a pre- or perinatal diagnosis TS who are born in a medical centre in the Netherlands during the duration of the study Main study parameters/endpoints: Serum levels of FSH, LH, AMH, inhibin B, testosterone and estradiol at the age of 3 and 9 months.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The subjects will have twice an extra venapunction for collection of 3.5mL blood during their infancy, which is not stated in the guidelines for TS. There is very little risk for adverse events associated with this blood sample collection, however it is an extra procedure. The outcome parameters will not be helpful for individual study participants, however they are likely to help clinicians and researchers in understanding how the ovarian function operates develops in girls with TS. Furthermore, these markers could be used to estimate the ovarian reserve and the urgency of fertility preservation in young females with TS. This information could help clinicians, patients and their parents in decision making.
Study Type
OBSERVATIONAL
Enrollment
30
A blood sample of 3.5 mL (0.2 mL serum for FSH and LH, 0.15 mL serum for E2, 0.15 mL serum for T, 0.15 mL serum for AMH and 0.25 mL serum for Inhibin B) will be collected of all girls with TS at 3 months and 9 months of age. For the girls with TS, this will be collected with an extra venapuncture during a regular outpatient visit within the usual care.
Righospitalet, University of Copenhagen
Copenhagen, Denmark
RECRUITINGUniversitätsklinikum der Ruhr-Universität Bochum
Bochum, Germany
RECRUITINGJustus-Liebig Universität Giessen
Giessen, Germany
RECRUITINGUniversitätsklinikum Tübingen
Tübingen, Germany
RECRUITINGRadboud University Medical Center
Nijmegen, Gelderland, Netherlands
RECRUITINGAmsterdam University medical center
Amsterdam, Netherlands
RECRUITINGUniversity medical center Groningen
Groningen, Netherlands
RECRUITINGLeiden University medical center
Leiden, Netherlands
RECRUITINGMaastricht University medical center
Maastricht, Netherlands
RECRUITINGErasmus University medical center
Rotterdam, Netherlands
RECRUITING...and 3 more locations
Defining the LH range in blood during minipuberty in girls with TS at 3 months of age and at 9 months of age
LH (luteinizing hormone) will be collected with a venapuncture and analysed with the Elecsys method on the Cobas E801system of Roche.
Time frame: 1 year after venapuncture
Defining the FSH range during minipuberty in girls with TS at 3 months of age and at 9 months of age
FSH (follicle stimulating hormone) will be collected with a venapuncture and analysed with the Elecsys method on the Cobas E801system of Roche.
Time frame: 1 year after venapuncture
Defining the AMH range during minipuberty in girls with TS at 3 months of age and at 9 months of age
AMH (Anti-Müllerian hormone) will be collected with a venapuncture and analysed on the Access of Beckman Coulter.
Time frame: 1 year after venapuncture
Defining the estradiol range during minipuberty in girls with TS at 3 months of age and at 9 months of age
estradiol will be collected with a venapuncture and analysed with the LCMSMS analysis method.
Time frame: 1 year after venapuncture
Defining the testosterone range during minipuberty in girls with TS at 3 months of age and at 9 months of age
testosterone will be collected with a venapuncture and analysed with the LCMSMS analysis method.
Time frame: 1 year
Defining the inhibin B range during minipuberty in girls with TS at 3 months of age and at 9 months of age
inhibin B will be collected with a venapuncture and analysed with the GEN II ELISEA of Beckman Coulter.
Time frame: 1 year after venapuncture
Patient's karyotype vs LH
The association between patient's karyotype and LH level at 3 months of age and 9 months of age
Time frame: 1 year after venapuncture
Patient's karyotype vs FSH
The association between patient's karyotype and FSH level at 3 months of age and 9 months of age
Time frame: 1 year after venapuncture
Patient's karyotype vs AMH
The association between patient's karyotype and AMH level at 3 months of age and 9 months of age
Time frame: 1 year after venapuncture
Patient's karyotype vs estradiol
The association between patient's karyotype and estradiol level at 3 months of age and 9 months of age
Time frame: 1 year after venapuncture
Patient's karyotype vs testosterone
The association between patient's karyotype and testosterone level at 3 months of age and 9 months of age
Time frame: 1 year after venapuncture
Patient's karyotype vs inhibin B
The association between patient's karyotype and inhibin B level at 3 months of age and 9 months of age
Time frame: 1 year after venapuncture
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.